A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The objective of this study is to investigate the patient acceptability/preference of Respimat® compared with Handihaler® in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) to demonstrate the superiority of Respimat®.
Epistemonikos ID: c9596318eee11151e9ffd2b89efeed6756b6cef1
First added on: May 22, 2024